Strengthening 'Strategic Investments' to Enhance Korea's Industrial Competitiveness

The sovereign wealth fund Korea Investment Corporation (KIC) will invest USD 150 million (approximately KRW 226.6 billion) to support overseas expansion of domestic bio companies. This marks the first time that KIC, which has focused on overseas investments, is providing direct support to Korean companies.


On March 23, KIC announced its decision to make this strategic investment in a global bio research and development (R&D) investment platform. KIC will participate as a co-investor as domestic companies expand overseas. Through this approach, companies gain momentum to pursue business abroad, while KIC secures a foundation for long-term revenue generation. The goal is not just financial investment, but also to enhance industrial competitiveness.


KIC plans to create a fund and jointly invest in the early clinical trials of domestic new drugs with several Korean bio companies pursuing overseas expansion. To this end, KIC has established a collaborative framework with CBC Group, an Asia-based bio and healthcare-focused global asset management firm. By leveraging CBC Group's network, KIC expects to strengthen connections with overseas pharmaceutical companies and investors, while also reducing investment risks.


Having focused on investments in overseas stocks, bonds, and alternative assets, KIC is now expected to contribute to strengthening the competitiveness of domestic industries through this investment. This move is seen as part of KIC’s strategy to gradually reinforce its role as a 'strategic investor' among sovereign wealth funds. Previously, KIC established a Strategic Investment Team in 2024 to support domestic companies’ global competitiveness and secure new growth engines, and in 2025 selected two domestic investment managers for strategic investments. Starting this year, KIC has expanded and reorganized the team into a Strategic Investment Division, focusing on such investments.



Il-Young Park, CEO of KIC, said, "This strategic investment decision is significant in that it creates a practical opportunity for domestic companies to take a leap forward in the global market," adding, "We will continue to seek investment opportunities that maximize synergy and enhance the competitiveness of domestic companies through collaboration with global asset managers."

KIC to Invest KRW 230 Billion in Korean Bio Companies... "Supporting Overseas Expansion" View original image


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing